HomeCompareJERCX vs JNJ

JERCX vs JNJ: Dividend Comparison 2026

JERCX yields 2.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JERCX wins by $3.3K in total portfolio value
10 years
JERCX
JERCX
● Live price
2.45%
Share price
$11.78
Annual div
$0.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.3K
Annual income
$286.87
Full JERCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JERCX vs JNJ

📍 JERCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJERCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JERCX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JERCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JERCX
Annual income on $10K today (after 15% tax)
$208.18/yr
After 10yr DRIP, annual income (after tax)
$243.84/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $459.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JERCX + JNJ for your $10,000?

JERCX: 50%JNJ: 50%
100% JNJ50/50100% JERCX
Portfolio after 10yr
$21.7K
Annual income
$557.33/yr
Blended yield
2.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JERCX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JERCX buys
0
JNJ buys
0
No recent congressional trades found for JERCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJERCXJNJ
Forward yield2.45%3.36%
Annual dividend / share$0.29$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.3K$20.0K
Annual income after 10y$286.87$827.78
Total dividends collected$2.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JERCX vs JNJ ($10,000, DRIP)

YearJERCX PortfolioJERCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,945$244.92$10,676$355.77+$269.00JERCX
2$11,962$250.52$11,407$389.39+$555.00JERCX
3$13,055$255.88$12,198$426.53+$857.00JERCX
4$14,230$261.00$13,056$467.62+$1.2KJERCX
5$15,492$265.87$13,987$513.12+$1.5KJERCX
6$16,846$270.52$14,998$563.56+$1.8KJERCX
7$18,301$274.93$16,098$619.52+$2.2KJERCX
8$19,861$279.12$17,295$681.69+$2.6KJERCX
9$21,534$283.10$18,599$750.82+$2.9KJERCX
10$23,328$286.87$20,022$827.78+$3.3KJERCX

JERCX vs JNJ: Complete Analysis 2026

JERCXStock

The fund pursues its investment objective by investing at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of real estate-related companies. Such companies may include those in the real estate industry or real estate-related industries. These securities may include common stocks, preferred stocks, and other equity securities, including, but not limited to, REITs and similar REIT-like entities, such as foreign entities that have REIT characteristics and real estate operating companies.

Full JERCX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JERCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JERCX vs SCHDJERCX vs JEPIJERCX vs OJERCX vs KOJERCX vs MAINJERCX vs ABBVJERCX vs MRKJERCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.